-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Definium Therapeutics, Maintains $66 Price Target

Benzinga·09/14/2026 11:50:16
Listen to the news
Needham analyst Ami Fadia reiterates Definium Therapeutics (NASDAQ:DFTX) with a Buy and maintains $66 price target.